Cryoglobulinaemia related to Sjögren's syndrome or HCV infection: Differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy

Rheumatology

Volumn 51, Issue 4, 2012, Pages 627-633

  De Vita, Salvatore ^a   Quartuccio, Luca ^a   Salvin, Sara ^a   Corazza, Laura ^a   Zabotti, Alen ^a   Fabris, Martina ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cryoglobulinaemia; Hepatitis; Lymphoma; Sj gren's syndrome

Indexed keywords

CRYOGLOBULIN; RHEUMATOID FACTOR;

ADULT; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; CELL EXPANSION; CLINICAL ARTICLE; CRYOGLOBULINEMIA; CRYOGLOBULINEMIC VASCULITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PAROTIDECTOMY; PREVALENCE; PRIORITY JOURNAL; SIALOADENITIS; SJOEGREN SYNDROME; VASCULITIS; AGED; BONE MARROW CELL; CASE CONTROL STUDY; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; PAROTID GLAND; PATHOLOGY; POSTOPERATIVE PERIOD; VIROLOGY;

ADULT; AGED; B-LYMPHOCYTES; BONE MARROW CELLS; CASE-CONTROL STUDIES; CRYOGLOBULINEMIA; DISEASE PROGRESSION; FEMALE; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; PAROTID GLAND; POSTOPERATIVE PERIOD; SJOGREN'S SYNDROME; VASCULITIS; YOUNG ADULT;

EID: 84858625929     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker407     Document Type: Article

References (29)

1. Tzioufas AG, Youinou P, Moutsopoulos HM. Sjögren's syndrome. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC, eds. Oxford Textbook of Rheumatology, 3rd edn. Oxford: Oxford University Press, 2004:921-33.
2. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine 2009;88:284-93.
3. Tzioufas AG, Boumbas DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996;39:767-72.
4. De Vita S, De Marchi G, Sacco S et al. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells Mol Dis 2001;27: 757-66.
5. Monti G, Pioltelli P, Saccardo F et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005;165:101-5.
6. Anaya JM, McGuff HS, Banks PM, Talal N. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 1996;25: 337-46.
7. De Vita S, Boiocchi M, Sorrentino D et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997;40:318-31.
8. Sutcliffe N, Inanc M, Speight P, Isenberg D. Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 1998;28:80-7.
9. Gasparotto D, De Vita S, De Re V et al. Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum 2003;48:3181-6.
10. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72.
11. Mazzaro C, De Re V, Spina M et al. Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas. Br J Haematol 2009;145:255-7.
12. Mazzaro C, Zagonel V, Monfardini S et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996;94: 544-50.
13. Sansonno D, De Vita S, Iacobelli AR et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160: 3594-601.
14. De Vita S, Sansonno D, Dolcetti R et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86: 1887-92.
15. Monteverde A, Ballarè M, Bertoncelli MC et al. Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13(Suppl. 13):S141-7.
16. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61: 554-8.
17. De Vita S, Soldano F, Isola M et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis 2011;70:1183-90.
18. Quartuccio L, Fabris M, Salvin S et al. Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis. Rheumatology 2007;46: 1657-61.
19. Quartuccio L, Fabris M, Moretti M et al. Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Open Rheumatol J 2008;2:38-43.
20. Ivanovski M, Silvestri F, Pozzato G et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998;91:2433-42.
21. De Vita S, De Re V, Gasparotto D et al. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. Arthritis Rheum 2000;43: 94-102.
22. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338: 1175-6.
23. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
24. Anderson LG, Cummings NA, Asofsky R et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med 1972;53:456-63.
25. Kipps TJ, Tomhave E, Chen PP, Fox RI. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome. J Immunol 1989;142:4261-8.
26. Sugai S, Shimizu S, Tachibana J et al. A high incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sjögren's syndrome. J Autoimmun 1989;2:471-6.
27. Shokri F, Mageed RA, Maziak BR et al. Lymphoproliferation in primary Sjögren's syndrome. Evidence of selective expansion of a B cell subset characterized by the expression of cross-reactive idiotypes. Arthritis Rheum 1993;36:1128-36.
28. Ramos-Casals M, la Civita L, de Vita S et al.; SS-HCV Study Group. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection. Arthritis Rheum 2007;57: 161-70.
29. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 2005;4:8-15.